Azenta Life Sciences Acquires Trans-hit Biomarkers
Azenta Life Sciences acquired Trans-hit Biomarkers for $15.1M. View deal terms, timeline, and press on Fsome.
Deal Details
- Acquirer
- Azenta Life Sciences
- Acquired Company
- Trans-hit Biomarkers
- Price
- $15.1M
- Acquisition Type
- Acquisition
- Announced
- December 3, 2020
Canonical: https://fsome.com/acquisitions/azenta-life-sciences-acquires-trans-hit-biomarkers-8052723 · For the full deal terms, timeline, and press references, please enable JavaScript.